phenylephrine 10% eye drops
martindale pharmaceuticals ltd - phenylephrine hydrochloride - eye drops - 100mg/1ml
phenylephrine 10% eye drops
alliance healthcare (distribution) ltd - phenylephrine hydrochloride - eye drops - 100mg/1ml
phenylephrine 500micrograms/10ml solution for injection pre-filled syringes
aguettant ltd - phenylephrine hydrochloride - solution for injection - 50microgram/1ml
phenylephrine 1mg/10ml solution for injection ampoules
martindale pharmaceuticals ltd - phenylephrine hydrochloride - solution for injection - 100microgram/1ml
minims phenylephrine hydrochloride 2.5% w/v eye drops, solution
bausch & lomb uk limited - phenylephrine hydrochloride - eye drops, solution - 2.5 percent weight/volume - sympathomimetics used as decongestants; phenylephrine
minims phenylephrine hydrochloride 10% 100mg/ml eye drops tube
bausch & lomb australia pty ltd - phenylephrine hydrochloride, quantity: 100 mg/ml - eye drops, solution - excipient ingredients: sodium metabisulfite; disodium edetate; purified water - phenylephrine is a directly acting sympathomimetic agent used topically in the eye as a mydriatic. minims phenylephrine hydrochloride eye drops are indicated to dilate the pupil for diagnostic or therapeutic procedures.
phenylephrine hydrochloride solution/ drops
a-s medication solutions - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - phenylephrine hydrochloride ophthalmic solution, usp 2.5% and 10%, is indicated to dilate the pupil. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in patients with hypertension or thyrotoxicosis. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in pediatric patients less than 1 year of age due to the increased risk of systemic toxicity. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients [see dosage and administration (2.2)] . animal reproduction studies have not been conducted with topical phenylephrine. it is also not known whether phenylephrine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. phenylephrine hydrochloride should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human breast milk. because many drugs are excreted in human milk, cau
phenylephrine hydrochloride solution/ drops
a-s medication solutions - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - phenylephrine hydrochloride ophthalmic solution, usp 2.5% and 10%, is indicated to dilate the pupil. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in patients with hypertension or thyrotoxicosis. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in pediatric patients less than 1 year of age due to the increased risk of systemic toxicity. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients [see dosage and administration (2.2)] . animal reproduction studies have not been conducted with topical phenylephrine. it is also not known whether phenylephrine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. phenylephrine hydrochloride should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human breast milk. because many drugs are excreted in human milk, cau
phenylephrine accord phenylephrine hydrochloride 10 mg/1 ml solution for injection vial
accord healthcare pty ltd - phenylephrine hydrochloride, quantity: 10 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; sodium citrate dihydrate; water for injections; citric acid monohydrate; sodium metabisulfite; sodium chloride - for the maintenance of an adequate level of blood pressure during spinal and inhalation anaesthesia and for the treatment of vascular failure in shock, shock-like states, and drug-induced hypotension, or hypersensitivity. it is also employed to overcome paroxysmal supraventricular tachycardia, to prolong spinal anaesthesia, and as a vasoconstrictor in regional analgesia
minims phenylephrine hydrochloride
bausch & lomb (nz) ltd - phenylephrine hydrochloride 10%; ; - eye drops, solution - 10 % - active: phenylephrine hydrochloride 10% excipient: disodium edetate dihydrate sodium metabisulfite water for injection